Single-Molecule Plasmonic Detection Nucleic Acid Patent: A 2025 Guide

The field of biosensing is moving toward the ability to detect a single molecule of a specific nucleic acid sequence without the need for amplification. A key technology in this area is single-molecule plasmonic detection. The core idea is that a single DNA or RNA molecule binding to a nanostructure alters the local refractive index, which shifts the plasmon resonance of that nanostructure in a detectable way. A “single-molecule plasmonic detection nucleic acid patent” generally covers the specific hardware, nanostructure design, or signal processing method that makes this single-molecule sensitivity possible.

How Plasmonic Detection Works at the Single-Molecule Level

Plasmonic detection relies on the interaction between light and conduction electrons in a metal nanostructure. When light hits a gold or silver nanoparticle smaller than the wavelength of light, the electrons oscillate collectively. This creates a strong, localized electromagnetic field near the particle surface. This phenomenon is called localized surface plasmon resonance (LSPR).

The resonance condition depends on the size, shape, and material of the nanoparticle, as well as the refractive index of the material immediately surrounding it. When a nucleic acid molecule binds to the surface of the nanoparticle, it displaces water or buffer, which changes the local refractive index. This causes a shift in the LSPR wavelength. For a single molecule, this shift is extremely small. Detecting that shift requires very stable optics, precise temperature control, and advanced data analysis.

Core Patent Claims in This Technology Area

Patents in this space typically claim a specific combination of elements that makes single-molecule detection reliable. Common claims include the geometry of the nanostructure, the method of functionalizing the surface with capture probes, and the optical setup used to measure the signal.

A typical claim might describe a nanoantenna structure, such as a gold nanorod dimer with a gap of a few nanometers. The gap creates a “hot spot” where the electromagnetic field is concentrated. A capture probe, such as a short DNA oligonucleotide, is attached to the surface inside this gap. When the target nucleic acid hybridizes to the probe, the change in refractive index within the gap produces a measurable LSPR shift. Some patents claim a method for correlating the magnitude of the shift with the number of bound molecules, enabling quantification.

Relationship to Single-Entity Electrochemistry

The patent landscape for plasmonic detection overlaps with the broader field of single-entity electrochemistry (SEE). SEE is the analysis of individual units (single molecules, nanoparticles, vesicles, or cells) rather than a bulk average Wikipedia. A key feature of SEE is that it unifies different branches of electrochemistry by allowing researchers to observe how a single entity contributes to the overall response.

In the context of nucleic acid detection, SEE techniques such as single-molecule redox cycling can measure the faradaic current produced by a single redox-labeled DNA molecule. This is a different physical principle from plasmonic detection, but both aim for the same goal: detecting a single binding event without amplification. Some patents combine both approaches, using a plasmonic nanostructure as the working electrode in an electrochemical cell. This hybrid approach can provide two independent signals (optical and electrical) for the same binding event, which improves confidence in the result.

Key Nanostructure Designs in the Patent Literature

Patent filings describe a variety of nanostructure designs optimized for single-molecule sensitivity. The most common is the gold nanorod, because its longitudinal plasmon resonance is highly sensitive to changes in the local refractive index. A nanorod with an aspect ratio of about 3.5 has a resonance in the near-infrared region, where biological samples have low background absorption.

Another design is the bowtie nanoantenna, which consists of two triangular gold structures pointing toward each other with a small gap. The electric field in the gap can be enhanced by several orders of magnitude. This design is often used in surface-enhanced Raman scattering (SERS) patents, where the signal from a single molecule can be amplified enough to be detected.

Nanohole arrays in a gold film are also common. These arrays create a surface plasmon polariton that propagates along the film. Binding of nucleic acids to the edges of the nanoholes changes the transmission spectrum through the array. This design is easier to fabricate at scale than isolated nanoparticles, which makes it attractive for commercial applications.

Optical Measurement Methods and Signal Processing

The optical setup for single-molecule plasmonic detection must be extremely stable. Most systems use a dark-field microscope to illuminate the nanoparticles and collect the scattered light. The scattered light is sent to a spectrometer, where the spectrum is recorded. A high-speed camera can track the position and spectrum of individual nanoparticles in real time.

Signal processing is a critical part of the patent claims. The raw spectrum from a single nanoparticle contains noise from thermal fluctuations, laser drift, and electronic noise. Patents often describe methods for filtering this noise, such as using a reference beam or a differential measurement between two nanoparticles on the same substrate. Some patents claim an algorithm that fits the spectrum to a Lorentzian function and tracks the peak wavelength over time. A sudden shift that persists for a certain duration is classified as a binding event.

Challenges in Commercialization and Clinical Use

Commercializing a single-molecule plasmonic detection system for nucleic acids faces several hurdles. The first is cost. The optical components, including a high-numerical-aperture objective, a sensitive spectrometer, and a low-noise camera, are expensive. The nanostructures themselves require nanofabrication facilities, which adds to the cost per test.

The second challenge is throughput. Most single-molecule systems image a small area of the sample, typically a few hundred microns across. This limits the number of targets that can be detected in a single run. Multiplexing (detecting many different sequences at once) requires either many different nanostructures or a way to spatially encode the capture probes.

The third challenge is robustness. The signal from a single nanoparticle can be affected by changes in temperature, pH, or salt concentration. Clinical samples such as blood or saliva contain many other molecules that can bind nonspecifically to the nanostructure surface. Patents often claim methods for blocking these nonspecific interactions, such as coating the surface with polyethylene glycol or using a self-assembled monolayer.

The Patent Filing Landscape

The number of patent applications in this area has grown steadily over the past decade. The World Intellectual Property Organization (WIPO) and the United States Patent and Trademark Office (USPTO) have published applications from universities, research institutes, and medical device companies WIPO, USPTO. Many of the early patents focused on the fundamental physics of the nanostructures, while more recent filings address practical issues such as sample preparation and data analysis.

A search on Google Patents for terms related to single-molecule plasmonic detection and nucleic acids returns several hundred results Google Patents. The distribution is international, with significant filings from the United States, China, South Korea, and the European Union. Companies with a strong presence in molecular diagnostics have also filed patents in this space, suggesting that they see plasmonic detection as a potential complement or alternative to existing methods.

Surface Functionalization Strategies for Capture Probes

The reliability of a single-molecule plasmonic detection assay depends heavily on how the capture probe is attached to the nanostructure surface. Gold surfaces are the most common substrate, and the standard attachment method uses a thiol-gold bond. A thiol-modified DNA oligonucleotide is mixed with the gold nanoparticles, and the sulfur atom forms a strong covalent bond to the gold surface.

The density of capture probes on the surface must be controlled carefully. If the probes are packed too densely, steric hindrance prevents the target nucleic acid from binding. If they are too sparse, the probability of a target molecule landing on a probe within the detection volume is low. Patents often claim a specific surface density range. Some methods use a mixed monolayer of thiolated DNA and a short spacer molecule, such as mercaptohexanol, to create the optimal spacing.

For non-gold surfaces, such as silver or aluminum, alternative chemistries are used. Silver surfaces can be functionalized with amine-terminated probes using carbodiimide crosslinkers. Aluminum surfaces require silane chemistry to attach a linker molecule. Each approach has its own patent claims covering the specific reaction conditions and concentrations.

Temperature and Buffer Control for Single-Molecule Stability

A single-molecule measurement can be disrupted by thermal drift, which causes the nanostructure to expand or contract slightly, shifting the plasmon resonance. Patents in this area often describe a temperature control system that maintains the sample at a constant temperature within a narrow range. This is typically achieved using a Peltier element under the sample stage.

The buffer composition also matters. High salt concentrations help stabilize the DNA duplex by screening the negative charges on the phosphate backbone. However, high salt can also cause aggregation of the gold nanoparticles. Patents claim specific buffer formulations that balance these two requirements. A common formulation is phosphate-buffered saline with a surfactant that reduces nonspecific adsorption without destabilizing the nanoparticles.

Another consideration is the pH of the buffer. Most DNA hybridization reactions work best at a pH between 7.0 and 8.5. Outside this range, the capture probe or the target molecule may change conformation, reducing binding affinity. Some patents claim a method for real-time pH monitoring inside the microfluidic channel that delivers the sample to the nanostructures.

Multiplexing Approaches for Multiple Target Sequences

Detecting more than one nucleic acid sequence in a single sample requires a multiplexing strategy. One approach is to use an array of nanostructures, where each spot on the array is functionalized with a different capture probe. The array can be fabricated by electron beam lithography or by directed assembly of nanoparticles. A patent might claim a specific pattern of nanostructures and a method for assigning each spot to a specific target.

Another approach uses the spectral properties of the nanoparticles themselves. Gold nanorods of different aspect ratios have different LSPR peak wavelengths. By using a mixture of nanorods, each with a different capture probe, a single measurement can track multiple binding events simultaneously. A spectrometer or a multispectral camera separates the signals based on wavelength. Patents claim the specific aspect ratios and the corresponding probe sequences that are attached to each type of nanorod.

A third approach uses spatial encoding with barcoded nanostructures. Each nanostructure has a unique shape or size that can be identified by its scattering pattern. By creating a library of shapes, each linked to a specific capture probe, the system can identify which target is present based on the shape of the nanostructure that shows a binding event. This approach is still largely in the research phase, but patent filings describe the fabrication methods and the decoding algorithms.

Integration with Microfluidics for Sample Delivery

Delivering the sample to the nanostructures in a controlled manner is essential for single-molecule detection. Microfluidic channels, typically made of polydimethylsiloxane (PDMS) or glass, are bonded to the substrate containing the nanostructures. The sample flows through the channel at a low flow rate. This slow flow allows the target molecules to diffuse to the surface and bind to the capture probes.

Patents claim specific channel geometries that minimize dead volume and ensure uniform flow across the array. A serpentine channel design is common because it provides a long path length in a small footprint. Some patents describe a method for stopping the flow after a certain time to allow the binding reaction to reach equilibrium, then resuming the flow to wash away unbound molecules.

For clinical samples, the microfluidic system must handle complex fluids such as whole blood or saliva. These fluids contain cells, proteins, and other debris that can clog the channels or bind to the nanostructures. Patents claim a pretreatment step, such as filtering the sample through a membrane or adding a lysis buffer to break open cells and release the nucleic acids.

Data Analysis Algorithms for Event Detection

The raw data from a single-molecule plasmonic detection experiment is a time series of LSPR peak wavelengths for each nanostructure. A binding event appears as a sudden step change in the wavelength, followed by a plateau. The challenge is to distinguish these events from noise.

Patents claim algorithms that use a threshold-based detection method. The algorithm calculates the baseline wavelength over a sliding window. If the wavelength deviates from the baseline by more than a certain threshold, the algorithm marks that time point as a potential binding event. The event is confirmed if the wavelength stays at the new value for a minimum duration.

More sophisticated algorithms use a hidden Markov model to infer the state of the nanostructure. The model has two states: bound and unbound. The algorithm calculates the probability that the system is in each state at each time point, based on the observed wavelength and the known transition rates. This approach can detect binding events even when the signal-to-noise ratio is low.

Some patents claim a method for correcting for drift over long measurement periods. Drift can be caused by temperature changes, photobleaching of the nanoparticles, or slow changes in the buffer refractive index. A reference nanostructure that is not functionalized with a capture probe provides a baseline signal. The algorithm subtracts the drift measured at the reference from the signal at the active nanostructures.

Key Takeaways

• Single-molecule plasmonic detection uses the shift in localized surface plasmon resonance caused by a single nucleic acid binding event to achieve amplification-free detection.
• Patents in this area typically claim specific nanostructure geometries, surface functionalization methods, and optical signal processing algorithms.
• The technology overlaps with single-entity electrochemistry, which measures individual molecules through electrochemical means rather than optical.
• Commercial adoption faces challenges in cost, throughput, and robustness in clinical samples.
• The patent landscape is international and growing, with filings from both academic institutions and commercial diagnostics companies.